Nutraceutical Excipients Market to Showcase Continued Growth in the Coming Years

By -

The Nutraceutical Excipients market is projected to grow from USD 3 Billion in 2016 to USD 4 Billion by 2022, at a CAGR of 7.6%.

Nutraceutical Excipients Market

(EMAILWIRE.COM, March 25, 2020 ) The report "Nutraceutical Excipients Market by Functionality (Fillers & Diluents, Coating Agents, Lubricants, and Flavoring Agents), End Product (Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins), Form (Dry and Liquid), and Region - Global Forecast to 2022", The nutraceutical excipients market is estimated at USD 2.96 Billion in 2017 and is projected to reach a value of USD 4.27 Billion by 2022, at a CAGR of 7.6%. The market is driven by factors such as the growing demand for nutraceuticals and advances in nanotechnology used in imparting new functions to excipients. The major players in the food industry are investing in research & development activities to expand their excipient product portfolios and attract more consumers by providing innovative products at lower prices.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247060367

Fillers & diluents account for the highest share in Nutraceutical Excipients Market

On the basis of functionality, the nutraceutical excipients market is segmented into binders, lubricants, fillers, disintegrants, coating agents, and flavoring agents. Fillers & diluents accounted for the largest market share during the forecast period. They meet varying demand from manufacturers. The popularity of excipients is attributed to their wide use in various applications, easy availability, and multifunctional nature.

Dry from dominated the Nutraceutical Excipients Market

The Nutraceutical Excipients market has been segmented on the basis of form into dry and liquid. Nutraceutical products require proper mixing of active nutraceutical ingredients and inactive ingredients such as excipients to ensure accurate distribution in the formulation. The major forms of nutraceutical excipients considered in the report are dry and liquid forms. Powder flowability is among the important determining factors responsible for influencing the optimal performance of an excipient. Excellent flow-ability of the excipient powder is an essential characteristic required for it to function as a filler, diluent, or a binder in nutraceutical products such as in orally dissolving tablet (ODT). The taste masking capabilities of an excipient in the form of powder also have significant effects on the acceptability of the end product, as an active nutraceutical ingredient often possesses an undesirable taste.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=247060367

North America dominated the nutraceutical excipients market in 2016.

North America accounted for the largest market share in 2016. The nutraceutical excipients market is consolidated in North America and dominated by a few companies such as DuPont, Kerry, Cargill, and Ingredion. The market for nutraceutical excipients here is mature, and hence, the growth is moderate compared to other regions.

This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies. It includes profiles of leading companies such as Kerry (Ireland), ABF (UK), DuPont (US), Ingredion (US), and Sensient (US), Roquette Frères (France), Meggle (Germany), Hilmar Ingredients (US), JRS Pharma (Germany), Innophos (US), Cargill (US), and IMCD (Netherlands).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more